Ipilimumab and Nivolumab for Treatment of Eyelid Spindle Cell Melanoma

被引：2
|
作者：
Shoji, Marissa K. [1 ,2 ]
Rong, Andrew J. [1 ,2 ]
机构：
[1] Univ Miami, Bascom Palmer Eye Inst, Miller Sch Med, Miami, FL USA
[2] Univ Miami, Bascom Palmer Eye Inst, Miller Sch Med, 900 NW 17th St, Miami, FL 33136 USA
来源：
AMERICAN JOURNAL OF OPHTHALMOLOGY | 2023年 / 250卷
关键词：
D O I：
10.1016/j.ajo.2023.02.010
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：E1 / E2
页数：2
相关论文
共 50 条
  • [21] Permanent bilateral mydriasis after treatment with nivolumab/ipilimumab for cutaneous melanoma
    Urbinati, F.
    Martin, F. Zamorano
    Anil, R. Rachwani
    Castano, P. Gutierrez
    Lorente, M. Garcia
    Mataix, B.
    Contreras, M. Espana
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2022, 45 (04): : E205 - E207
  • [22] Eosinophilic Pneumonia Following Treatment with Nivolumab-Ipilimumab for Metastatic Melanoma
    Wajda, N. A.
    Pina, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [23] Ipilimumab in combination with nivolumab for the treatment of renal cell carcinoma
    Gao, Xin
    McDermott, David F.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (09) : 947 - 957
  • [24] Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
    Larkin, J.
    Chiarion-Sileni, V.
    Gonzalez, R.
    Grob, J. J.
    Cowey, C. L.
    Lao, C. D.
    Schadendorf, D.
    Dummer, R.
    Smylie, M.
    Rutkowski, P.
    Ferrucci, P. F.
    Hill, A.
    Wagstaff, J.
    Carlino, M. S.
    Haanen, J. B.
    Maio, M.
    Marquez-Rodas, I.
    McArthur, G. A.
    Ascierto, P. A.
    Long, G. V.
    Callahan, M. K.
    Postow, M. A.
    Grossmann, K.
    Sznol, M.
    Dreno, B.
    Bastholt, L.
    Yang, A.
    Rollin, L. M.
    Horak, C.
    Hodi, F. S.
    Wolchok, J. D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (01): : 23 - 34
  • [25] Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
    Tawbi, Hussein A.
    Forsyth, Peter A.
    Algazi, Alain
    Hamid, Omid
    Hodi, F. Stephen
    Moschos, Stergios J.
    Khushalani, Nikhil I.
    Lewis, Karl
    Lao, Christopher D.
    Postow, Michael A.
    Atkins, Michael B.
    Ernstoff, Marc S.
    Reardon, David A.
    Puzanov, Igor
    Kudchadkar, Ragini R.
    Thomas, Reena P.
    Tarhini, Ahmad
    Pavlick, Anna C.
    Jiang, Joel
    Avila, Alexandre
    Demelo, Sheena
    Margolin, Kim
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (08): : 722 - 730
  • [26] Ipilimumab Re-exposition after Pre-treatment with Ipilimumab and Nivolumab for metastatic Mucosal Melanoma
    Steinke, H.
    von, Bubnoff D.
    Heinrich, C.
    Meiss, F.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 : 29 - 29
  • [27] Nivolumab plus ipilimumab in melanoma brain metastases
    Giacomo, Anna Maria Di
    Maio, Michele
    LANCET ONCOLOGY, 2022, 23 (02): : E53 - E53
  • [28] Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain Reply
    Tawbi, Hussein A.
    Chung, Caroline
    Margolin, Kim
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22): : 2178 - 2178
  • [29] Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
    Valsecchi, Matias E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (13): : 1270 - 1270
  • [30] NIVOLUMAB IS ACTIVE IN IPILIMUMAB-REFRACTORY MELANOMA
    不详
    CANCER DISCOVERY, 2013, 3 (12) : 1326 - 1326
12345